{"id":14037,"date":"2025-09-04T09:16:43","date_gmt":"2025-09-04T07:16:43","guid":{"rendered":"https:\/\/www.cilcare.com\/?p=14037"},"modified":"2025-09-04T09:17:45","modified_gmt":"2025-09-04T07:17:45","slug":"cilcare-appoints-camille-rochmann-as-evidence-value-access-senior-manager","status":"publish","type":"post","link":"https:\/\/www.cilcare.com\/jp\/2025\/09\/04\/cilcare-appoints-camille-rochmann-as-evidence-value-access-senior-manager\/","title":{"rendered":"Cilcare appoints Camille Rochmann as Evidence, Value &#038; Access Senior Manager"},"content":{"rendered":"<p><strong>Montpellier, France, September 4<sup>th<\/sup> 2025 : Cilcare, a biotechnology company specializing in auditory sciences, is pleased to announce the appointment of Camille Rochmann, PharmD, as Evidence, Value &amp; Access Senior Manager. In this role, Camille will lead Cilcare\u2019s strategy for evidence generation and market access, ensuring that innovation in hearing health is supported by robust data and aligned with regulatory and payer expectations from the earliest stages of development.<\/strong><\/p>\n\n\n\n<p>Camille brings over seven years of experience at Sanofi, where she worked on global and affiliate-level strategies in <strong>Health Economics and Outcomes Research (HEOR)<\/strong>, particularly in the field of rare diseases. Based in <strong>Boston and Paris<\/strong>, she led initiatives in real-world evidence generation, regulatory engagement (EMA, FDA), and the design of patient-centered clinical endpoints to support product access and positioning.<\/p>\n\n\n\n<p>At Cilcare, Camille will be responsible for developing and executing value and evidence strategies that support both clinical innovation and regulatory success. She will work closely with internal teams to incorporate patient-centered and payer-relevant endpoints into clinical trials, and guide health economics activities in compliance with global regulatory requirements.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p><em>\u201cWe are thrilled to welcome Camille to the Cilcare team,\u201d<\/em> said <strong>Celia Belline<\/strong>, CEO and Co-founder of Cilcare. <em>\u201cCamille\u2019s strategic insights, scientific expertise, and deep understanding of market access will be instrumental in advancing our lead candidate CIL001 toward clinical and commercial success. Her contributions will also strengthen the positioning of our diagnostic tool for cochlear synaptopathy, helping us demonstrate its value to stakeholders and accelerate its adoption in the hearing health landscape.\u201d<\/em><\/p>\n<\/blockquote>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p><em>&#8220;I\u2019m excited to join a company that is pushing boundaries in hearing health,&#8221;<\/em> said <strong>Camille Rochmann<\/strong>. <em>&#8220;Bringing effective and accessible treatments to patients with hearing disorders requires a strong alignment between scientific innovation and the evidence that payers, providers, and regulators need. I look forward to supporting Cilcare\u2019s mission with a value-driven, evidence-based approach.&#8221;<\/em><\/p>\n<\/blockquote>\n\n\n\n<p>Camille holds a Doctor of Pharmacy (PharmD) and a Master\u2019s degree in Pharmacoeconomics &amp; Market Access from Paris-Saclay University. Her appointment reflects Cilcare\u2019s growing commitment to embedding market access strategy into every phase of product development and to ensuring the long-term success of its innovations \u2014 from diagnostics to therapeutics.<\/p>\n\n\n\n<p><strong>About Cilcare:<\/strong>&nbsp;Cilcare is a biotechnology company specializing in auditory sciences, developing cutting-edge solutions for the characterization, diagnosis, and treatment of hearing disorders and associated diseases. Founded in 2014 by three visionary entrepreneurs, Cilcare addresses global hearing health challenges by combining an advanced R&amp;D platform, a promising drug candidate portfolio, and the use of artificial intelligence and machine learning to characterize various forms of hearing loss.<\/p>\n\n\n\n<p>For the past 10 years, Cilcare has also made its technology available to industry leaders and researchers in Europe, the United States, and Asia to accelerate the development of drugs, gene and cell therapies, and medical devices for hearing disorders.<\/p>\n\n\n\n<p>Press contact:<\/p>\n\n\n\n<p>Marie PEYTAVY-IZARD Director of Marketing &amp; Communication<\/p>\n\n\n\n<p><a href=\"about:blank\">marie.peytavy@cilcare.com<\/a><\/p>\n\n\n\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>Montpellier, France, September 4th 2025 : Cilcare, a biotechnology company specializing in auditory sciences, is pleased to announce the appointment of Camille Rochmann, PharmD, as Evidence, Value &amp; Access Senior Manager. In this role, Camille will lead Cilcare\u2019s strategy for evidence generation and market access, ensuring that innovation in hearing health is supported by robust data and aligned with regulatory and payer expectations from the earliest stages of development. Camille brings over seven years of experience at Sanofi, where she worked on global and affiliate-level strategies in Health Economics and Outcomes Research (HEOR), particularly in the field of rare diseases. Based in Boston and Paris, she led initiatives in real-world [&hellip;]<\/p>","protected":false},"author":6,"featured_media":14039,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[113],"tags":[136],"class_list":["post-14037","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-appointment","tag-therapeutic-approaches-to-hidden-hearing-loss-celia-belline-featured-on-this-week-in-hearing","entry","has-media"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Cilcare appoints Camille Rochmann as Evidence, Value &amp; Access Senior Manager - Cilcare<\/title>\n<meta name=\"description\" content=\"Cilcare wins prestigious Hearing Technology Innovator Award for CIL001\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cilcare.com\/jp\/2025\/09\/04\/cilcare-appoints-camille-rochmann-as-evidence-value-access-senior-manager\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cilcare appoints Camille Rochmann as Evidence, Value &amp; Access Senior Manager - Cilcare\" \/>\n<meta property=\"og:description\" content=\"Cilcare wins prestigious Hearing Technology Innovator Award for CIL001\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cilcare.com\/jp\/2025\/09\/04\/cilcare-appoints-camille-rochmann-as-evidence-value-access-senior-manager\/\" \/>\n<meta property=\"og:site_name\" content=\"Cilcare\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-04T07:16:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-04T07:17:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2025\/09\/Camille-Rochmann_resize-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"2560\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"marie.peytavy\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"marie.peytavy\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cilcare.com\/2025\/09\/04\/cilcare-appoints-camille-rochmann-as-evidence-value-access-senior-manager\/\",\"url\":\"https:\/\/www.cilcare.com\/2025\/09\/04\/cilcare-appoints-camille-rochmann-as-evidence-value-access-senior-manager\/\",\"name\":\"Cilcare appoints Camille Rochmann as Evidence, Value & Access Senior Manager - Cilcare\",\"isPartOf\":{\"@id\":\"https:\/\/www.cilcare.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cilcare.com\/2025\/09\/04\/cilcare-appoints-camille-rochmann-as-evidence-value-access-senior-manager\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cilcare.com\/2025\/09\/04\/cilcare-appoints-camille-rochmann-as-evidence-value-access-senior-manager\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2025\/09\/Camille-Rochmann_resize-scaled.jpg\",\"datePublished\":\"2025-09-04T07:16:43+00:00\",\"dateModified\":\"2025-09-04T07:17:45+00:00\",\"author\":{\"@id\":\"https:\/\/www.cilcare.com\/#\/schema\/person\/345b0ccb59d96b17a6908a76cad8e256\"},\"description\":\"Cilcare wins prestigious Hearing Technology Innovator Award for CIL001\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cilcare.com\/2025\/09\/04\/cilcare-appoints-camille-rochmann-as-evidence-value-access-senior-manager\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cilcare.com\/2025\/09\/04\/cilcare-appoints-camille-rochmann-as-evidence-value-access-senior-manager\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\/\/www.cilcare.com\/2025\/09\/04\/cilcare-appoints-camille-rochmann-as-evidence-value-access-senior-manager\/#primaryimage\",\"url\":\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2025\/09\/Camille-Rochmann_resize-scaled.jpg\",\"contentUrl\":\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2025\/09\/Camille-Rochmann_resize-scaled.jpg\",\"width\":1920,\"height\":2560,\"caption\":\"Camille Rochmann\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cilcare.com\/2025\/09\/04\/cilcare-appoints-camille-rochmann-as-evidence-value-access-senior-manager\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cilcare.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cilcare appoints Camille Rochmann as Evidence, Value &#038; Access Senior Manager\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cilcare.com\/#website\",\"url\":\"https:\/\/www.cilcare.com\/\",\"name\":\"Cilcare\",\"description\":\"Making hearing a priority\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cilcare.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cilcare.com\/#\/schema\/person\/345b0ccb59d96b17a6908a76cad8e256\",\"name\":\"marie.peytavy\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\/\/www.cilcare.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5de15f4de6ecabd3b374a0d5608780aae06de6510a1b70c8fdf69e014f99cfbc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5de15f4de6ecabd3b374a0d5608780aae06de6510a1b70c8fdf69e014f99cfbc?s=96&d=mm&r=g\",\"caption\":\"marie.peytavy\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cilcare appoints Camille Rochmann as Evidence, Value & Access Senior Manager - Cilcare","description":"Cilcare wins prestigious Hearing Technology Innovator Award for CIL001","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cilcare.com\/jp\/2025\/09\/04\/cilcare-appoints-camille-rochmann-as-evidence-value-access-senior-manager\/","og_locale":"ja_JP","og_type":"article","og_title":"Cilcare appoints Camille Rochmann as Evidence, Value & Access Senior Manager - Cilcare","og_description":"Cilcare wins prestigious Hearing Technology Innovator Award for CIL001","og_url":"https:\/\/www.cilcare.com\/jp\/2025\/09\/04\/cilcare-appoints-camille-rochmann-as-evidence-value-access-senior-manager\/","og_site_name":"Cilcare","article_published_time":"2025-09-04T07:16:43+00:00","article_modified_time":"2025-09-04T07:17:45+00:00","og_image":[{"width":1920,"height":2560,"url":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2025\/09\/Camille-Rochmann_resize-scaled.jpg","type":"image\/jpeg"}],"author":"marie.peytavy","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"marie.peytavy","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cilcare.com\/2025\/09\/04\/cilcare-appoints-camille-rochmann-as-evidence-value-access-senior-manager\/","url":"https:\/\/www.cilcare.com\/2025\/09\/04\/cilcare-appoints-camille-rochmann-as-evidence-value-access-senior-manager\/","name":"Cilcare appoints Camille Rochmann as Evidence, Value & Access Senior Manager - Cilcare","isPartOf":{"@id":"https:\/\/www.cilcare.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cilcare.com\/2025\/09\/04\/cilcare-appoints-camille-rochmann-as-evidence-value-access-senior-manager\/#primaryimage"},"image":{"@id":"https:\/\/www.cilcare.com\/2025\/09\/04\/cilcare-appoints-camille-rochmann-as-evidence-value-access-senior-manager\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2025\/09\/Camille-Rochmann_resize-scaled.jpg","datePublished":"2025-09-04T07:16:43+00:00","dateModified":"2025-09-04T07:17:45+00:00","author":{"@id":"https:\/\/www.cilcare.com\/#\/schema\/person\/345b0ccb59d96b17a6908a76cad8e256"},"description":"Cilcare wins prestigious Hearing Technology Innovator Award for CIL001","breadcrumb":{"@id":"https:\/\/www.cilcare.com\/2025\/09\/04\/cilcare-appoints-camille-rochmann-as-evidence-value-access-senior-manager\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cilcare.com\/2025\/09\/04\/cilcare-appoints-camille-rochmann-as-evidence-value-access-senior-manager\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/www.cilcare.com\/2025\/09\/04\/cilcare-appoints-camille-rochmann-as-evidence-value-access-senior-manager\/#primaryimage","url":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2025\/09\/Camille-Rochmann_resize-scaled.jpg","contentUrl":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2025\/09\/Camille-Rochmann_resize-scaled.jpg","width":1920,"height":2560,"caption":"Camille Rochmann"},{"@type":"BreadcrumbList","@id":"https:\/\/www.cilcare.com\/2025\/09\/04\/cilcare-appoints-camille-rochmann-as-evidence-value-access-senior-manager\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cilcare.com\/"},{"@type":"ListItem","position":2,"name":"Cilcare appoints Camille Rochmann as Evidence, Value &#038; Access Senior Manager"}]},{"@type":"WebSite","@id":"https:\/\/www.cilcare.com\/#website","url":"https:\/\/www.cilcare.com\/","name":"Cilcare","description":"Making hearing a priority","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cilcare.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Person","@id":"https:\/\/www.cilcare.com\/#\/schema\/person\/345b0ccb59d96b17a6908a76cad8e256","name":"marie.peytavy","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/www.cilcare.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5de15f4de6ecabd3b374a0d5608780aae06de6510a1b70c8fdf69e014f99cfbc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5de15f4de6ecabd3b374a0d5608780aae06de6510a1b70c8fdf69e014f99cfbc?s=96&d=mm&r=g","caption":"marie.peytavy"}}]}},"_links":{"self":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/posts\/14037","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/comments?post=14037"}],"version-history":[{"count":2,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/posts\/14037\/revisions"}],"predecessor-version":[{"id":14040,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/posts\/14037\/revisions\/14040"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/media\/14039"}],"wp:attachment":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/media?parent=14037"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/categories?post=14037"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/tags?post=14037"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}